[go: up one dir, main page]

WO2016125159A1 - Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère - Google Patents

Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère Download PDF

Info

Publication number
WO2016125159A1
WO2016125159A1 PCT/IL2016/050124 IL2016050124W WO2016125159A1 WO 2016125159 A1 WO2016125159 A1 WO 2016125159A1 IL 2016050124 W IL2016050124 W IL 2016050124W WO 2016125159 A1 WO2016125159 A1 WO 2016125159A1
Authority
WO
WIPO (PCT)
Prior art keywords
stimulation
treatment
brain region
brain
predetermined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2016/050124
Other languages
English (en)
Inventor
Iftach DOLEV
Hilla FOGEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nibs Neuroscience Technologies Ltd
Original Assignee
Nibs Neuroscience Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nibs Neuroscience Technologies Ltd filed Critical Nibs Neuroscience Technologies Ltd
Priority to US15/547,502 priority Critical patent/US10485470B2/en
Priority to EP16746239.9A priority patent/EP3253445A4/fr
Publication of WO2016125159A1 publication Critical patent/WO2016125159A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/377—Electroencephalography [EEG] using evoked responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A61N1/36031—Control systems using physiological parameters for adjustment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4094—Diagnosing or monitoring seizure diseases, e.g. epilepsy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
    • A61M2021/005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense images, e.g. video
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Definitions

  • the directed inspective stimulation unit and the directed treatment stimulation unit are directed brain stimulation operable in at least a first mode of operation and a second mode of operation, such that at the first mode of operation the directed brain stimulation is configured to induce an examinatorial stimulation to a predetermined brain region of the subject, and at the first mode of operation the directed brain stimulation is configured to induce a treatment stimulation to the predetermined brain region based on the evaluated neuroplasticity of the neural structures in the predetermined brain region.
  • the term "early detection” of the cognitive condition may refer to a detection of the condition even before associated symptoms are apparent.
  • the stimulation includes inducing a magnetic flux/field to the brain or portions thereof.
  • the magnetic stimulation may include a Transcranial-Magnetic-stimulation (TMS).
  • TMS Transcranial-Magnetic-stimulation
  • the stimulation may include multiple TMS magnetic pulses at determined intensities.
  • the TMS intensity may refer to the flux of the induced magnetic field.
  • the TMS intensity may be measured/presented in Tesla units.
  • the TMS intensity may be measured/presented as a percentage of a reference value.
  • measuring the reactive activity may be facilitated by measuring an electric activity of neural structures in the brain in response to an electric/electromagnetic stimulation.
  • At least some brain activity sensors such as EEG-electrodes 104 are placed on the head of subject 152, and configured to measure neural activity of the brain of subject 152 or defined areas thereof for assessing a neural activity response to the diagnostic stimulation.
  • EEG-electrodes 104 are in communicational link with an analyzer/controller, such as an EEG-analyzer 114, configured to obtain EEG signals from EEG-electrodes 104.
  • EEG-analyzer 114 is configured to detect neuroplasticity of the targeted brain regions of subject 152 (or neural structures thereof) by measuring the intensities of the reactive activity and comparing the ratios between various pairs therefrom, and comparing the intensities with model/reference activities expected assuming various conditions and/or lack thereof. According to some embodiments, EEG-analyzer 114 is configured to analyze the
  • a treatment stimulation mechanism such as transcranial current stimulation (tCS) device 120, which is configured to provide treatment of brain stimulation to the target brain regions by sending an electric signal through a cathode 122 and an anode 124 placed on subject 152 at desired positions for inducing stimulation to the target brain regions.
  • tCS transcranial current stimulation
  • a stimulation burst may include 1 or more stimuli pulses.
  • a stimulation burst may include 2 or more stimuli pulses.
  • a stimulation burst may include 3 or more stimuli pulses.
  • a stimulation burst may include 4 or more stimuli pulses.
  • a stimulation burst may include 5 or more stimuli pulses.
  • a stimulation burst may include 2 to 10 stimuli pulses.
  • a stimulation burst may include 10 or more stimuli pulses.
  • a session of diagnosis and treatment is provided by performing diagnosis (assessment of neuroplasticity) and providing treatment stimulation.
  • an efficiency of a treatment may be evaluated by performing another diagnosis (assessment of neuroplasticity), and based on the effectiveness assessment, another treatment session may be provided.
  • parameters and characteristics of the second and following treatment sessions may be determined based on the assessed effectiveness of the first treatment.
  • the stimulation burst includes four stimulation pulses, the EEG recording thereof is illustrated in a first pulse recording 406a, a second pulse recording 406b, a third pulse recording 406c and a fourth pulse recording 406d.
  • a response recording namely a first response recording 408a, a second response recording 408b, a third response recording 408c and a fourth response recording 408d.
  • second response recording 408b and third response recording 408c are greater than first response recording 408a, which may be attributed to the excitability or plasticity characteristics of the relevant neural network, while forth response recording 408d is considerably reduced compared to the rest of the responses recorded, which may be attributed to the adaptation characteristics of the relevant neural network.
  • the TMS stimulation intensity is a "sub-threshold", selected to be of a lower intensity than the stimulation threshold.
  • the analysis is conducted after the stimulation session. According to some embodiments, the analysis is conducted during the stimulation session.
  • neuroneuron As used herein, the terms “neuron”, “neuro-structure”, “neural network” may be interchangeable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Neurosurgery (AREA)
  • Social Psychology (AREA)
  • Acoustics & Sound (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

La présente invention concerne des méthodes, des systèmes et des dispositifs permettant de détecter et de traiter des déficiences cognitives par induction d'une stimulation dans une région cérébrale prédéfinie, mesure de la réponse de l'activité neuronale suite à la stimulation et évaluation d'une neuroplasticité des structures neuronales dans une région cérébrale prédéfinie, puis par stimulation de la région cérébrale prédéfinie pour traiter la déficience cognitive.
PCT/IL2016/050124 2015-02-03 2016-02-03 Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère Ceased WO2016125159A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US15/547,502 US10485470B2 (en) 2015-02-03 2016-02-03 Early diagnosis and treatment of Alzheimer disease and mild cognitive impairment
EP16746239.9A EP3253445A4 (fr) 2015-02-03 2016-02-03 Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562111123P 2015-02-03 2015-02-03
US201562111122P 2015-02-03 2015-02-03
US62/111,123 2015-02-03
US62/111,122 2015-02-03

Publications (1)

Publication Number Publication Date
WO2016125159A1 true WO2016125159A1 (fr) 2016-08-11

Family

ID=56563555

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2016/050124 Ceased WO2016125159A1 (fr) 2015-02-03 2016-02-03 Diagnostic précoce, traitement de la maladie d'alzheimer et d'une déficience cognitive légère

Country Status (3)

Country Link
US (1) US10485470B2 (fr)
EP (1) EP3253445A4 (fr)
WO (1) WO2016125159A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600110051A1 (it) * 2016-11-02 2018-05-02 Univ Degli Studi Di Brescia Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema
WO2018237023A1 (fr) * 2017-06-20 2018-12-27 The Trustees Of Columbia University In The City Of New York Système, procédé et support accessible par un ordinateur permettant de déterminer la possibilité/probabilité d'un trouble mental
US20220240833A1 (en) * 2021-02-03 2022-08-04 Synchron Australia Pty Limited Neuromonitoring diagnostic systems

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3253451A4 (fr) * 2015-02-03 2018-02-21 Nibs Neuroscience Technologies Ltd. Diagnostic et traitement de la douleur chronique
IL281350B2 (en) * 2018-09-13 2025-06-01 Quantalx Neuroscience Ltd A reliable tool for evaluating brain health
US11553871B2 (en) * 2019-06-04 2023-01-17 Lab NINE, Inc. System and apparatus for non-invasive measurement of transcranial electrical signals, and method of calibrating and/or using same for various applications
US11270799B2 (en) * 2019-08-20 2022-03-08 Vinya Intelligence Inc. In-home remote monitoring systems and methods for predicting health status decline
US20210398678A1 (en) * 2020-06-16 2021-12-23 Washington University Systems and methods for monitoring functional neuroplasticity
WO2022167542A1 (fr) * 2021-02-04 2022-08-11 University Of Geneva Traitement de tacs guidé par eeg haute densité lié à une tâche pour les déficits cognitifs et comportementaux
AU2022306382A1 (en) 2021-07-06 2024-02-08 Sinaptica Therapeutics, Inc. Systems and methods for providing personalized targeted non-invasive stimulation to a brain network
CA3260828A1 (fr) * 2022-06-29 2024-01-04 Sinaptica Therapeutics Inc Systèmes et méthodes pour caractériser une réponse individuelle à une perturbation cérébrale chez des patients atteints de la maladie d'alzheimer
CN115501483A (zh) * 2022-11-15 2022-12-23 深圳中科华意科技有限公司 一种个性化经颅电刺激干预认知障碍的方法及装置
WO2024134614A1 (fr) * 2022-12-23 2024-06-27 Quantalx Neuroscience Ltd Bobine de stimulation magnétique
CN116251293A (zh) * 2023-01-05 2023-06-13 浙江脑动极光医疗科技有限公司 一种基于皮层网络补偿机制的认知评估训练方法及系统
WO2025126038A1 (fr) * 2023-12-11 2025-06-19 Quantalx Neuroscience Ltd Identification d'une maladie cérébrovasculaire et d'une atrophie temporelle médiale

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009044271A2 (fr) * 2007-10-04 2009-04-09 Neuronix Ltd. Systèmes et méthodes de traitement d'états pathologiques associés au système nerveux central et destinés à améliorer les fonctions cognitives

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5263481A (en) 1992-05-21 1993-11-23 Jens Axelgaard Electrode system with disposable gel
US5833622A (en) 1994-04-04 1998-11-10 Graphic Controls Corporation Non-invasive fetal probe having improved mechanical and electrical properties
CA2280046A1 (fr) 1997-02-17 1998-08-20 Kowa Co., Ltd. Dispositif pour iontophorese
US6498181B1 (en) 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US6671555B2 (en) 2001-04-27 2003-12-30 Medtronic, Inc. Closed loop neuromodulation for suppression of epileptic activity
US20100324441A1 (en) 2002-02-04 2010-12-23 Hargrove Jeffrey B Brain-Related Chronic Pain Disorder Treatment Method and Apparatus
US20060258788A1 (en) 2005-05-13 2006-11-16 Scott Coggins Polymeric hydrogel compositions
US7894905B2 (en) 2006-03-13 2011-02-22 Neuropace, Inc. Implantable system enabling responsive therapy for pain
WO2007138595A2 (fr) 2006-05-31 2007-12-06 Michael Naroditsky Dispositif thérapeutique électrique transcutané
US20090105576A1 (en) 2007-10-22 2009-04-23 Nam Hoai Do Electrode conductive element
EP2155056B1 (fr) 2007-05-22 2011-03-23 Persyst Development Corporation Procede et dispositif permettant un encliquetage rapide sur une electrode eeg
US20100298623A1 (en) 2007-10-24 2010-11-25 Mishelevich David J Intra-session control of transcranial magnetic stimulation
CN102202571A (zh) 2008-10-31 2011-09-28 内克斯蒂姆股份公司 用于当目标肌肉处于合适地活动时的非侵入式大脑刺激的方法、设备和计算机程序
BRPI0918700B8 (pt) 2008-12-30 2021-06-22 Univ City New York Res Found conjuntos de eletrodo e aparelhos para a estimulação neurocraniana
US8457731B2 (en) 2009-02-16 2013-06-04 Wisconsin Alumni Research Foundation Method for assessing anesthetization
WO2010146220A1 (fr) 2009-06-17 2010-12-23 Nexstim Oy Dispositif et procédé de stimulation magnétique
EP3744393B1 (fr) 2009-11-12 2022-04-27 Neosync, INC. Systèmes et procédés pour une synchronisation neuro-électro-encéphalographique (eeg)
US20110224571A1 (en) 2009-11-16 2011-09-15 Alvaro Pascual-Leone Non-invasive methods for evaluating cortical plasticity impairments
US8838247B2 (en) 2010-01-06 2014-09-16 Evoke Neuroscience, Inc. Transcranial stimulation device and method based on electrophysiological testing
WO2012048319A2 (fr) 2010-10-08 2012-04-12 Cervel Neurotech, Inc. Placement de bobine de stimulation magnétique transcranienne transversale pour analgésie améliorée
US20140058189A1 (en) 2012-02-20 2014-02-27 William F. Stubbeman Systems and methods using brain stimulation for treating disorders
US20140276184A1 (en) 2013-03-15 2014-09-18 Nexstim Method and system for tms dose assessment and seizure detection
WO2015034981A1 (fr) 2013-09-06 2015-03-12 Med-El Elektromedizinische Geraete Gmbh Contact d'électrode à revêtement d'hydrogel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009044271A2 (fr) * 2007-10-04 2009-04-09 Neuronix Ltd. Systèmes et méthodes de traitement d'états pathologiques associés au système nerveux central et destinés à améliorer les fonctions cognitives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3253445A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600110051A1 (it) * 2016-11-02 2018-05-02 Univ Degli Studi Di Brescia Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema
WO2018083580A1 (fr) * 2016-11-02 2018-05-11 Universita' Degli Studi Di Brescia Procédé de génération d'un indice de diagnostic de la maladie d'alzheimer, appareil électronique permettant la mise en œuvre du procédé et système
WO2018237023A1 (fr) * 2017-06-20 2018-12-27 The Trustees Of Columbia University In The City Of New York Système, procédé et support accessible par un ordinateur permettant de déterminer la possibilité/probabilité d'un trouble mental
US12097037B2 (en) 2017-06-20 2024-09-24 The Trustees Of Columbia University In The City Of New York System, method and computer-accessible medium for determining possibility/likelihood of mental disorder
US20220240833A1 (en) * 2021-02-03 2022-08-04 Synchron Australia Pty Limited Neuromonitoring diagnostic systems

Also Published As

Publication number Publication date
EP3253445A1 (fr) 2017-12-13
US20180014772A1 (en) 2018-01-18
US10485470B2 (en) 2019-11-26
EP3253445A4 (fr) 2018-02-21

Similar Documents

Publication Publication Date Title
US10485470B2 (en) Early diagnosis and treatment of Alzheimer disease and mild cognitive impairment
US20180008827A1 (en) Diagnosis and treatment of chronic pain
US8929991B2 (en) Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US7620456B2 (en) Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures
US20070088403A1 (en) Methods and systems for establishing parameters for neural stimulation
Bestmann et al. Mapping causal interregional influences with concurrent TMS–fMRI
JP6012466B2 (ja) 磁気刺激デバイスおよび方法
CN107613860B (zh) 脑神经活动监测
US8262714B2 (en) Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods
US20080103548A1 (en) Methods for treating neurological disorders, including neuropsychiatric and neuropsychological disorders, and associated systems
US20110028859A1 (en) Methods, Systems and Devices for Monitoring a Target in a Neural System and Facilitating or Controlling a Cell Therapy
US20140303424A1 (en) Methods and systems for diagnosis and treatment of neural diseases and disorders
US9339642B1 (en) System and method for conducting multi-electrode electrical stimulation
WO2009044271A2 (fr) Systèmes et méthodes de traitement d'états pathologiques associés au système nerveux central et destinés à améliorer les fonctions cognitives
US20170332934A1 (en) Neurocerebral assessment using stimulated eeg response
Kwak et al. Effect of temporal interference electrical stimulation on phasic dopamine release in the striatum
US20190117980A1 (en) Brain tissue stimulation method, apparatus and computer program
Yoshikawa et al. Temporal and spatial profiles of evoked activity induced by magnetic stimulation using millimeter-sized coils in the mouse auditory cortex in vivo
US20080015458A1 (en) Methods of diagnosing and treating neuropsychological disorders
Tehovnik et al. Delaying visually guided saccades by microstimulation of macaque V1: spatial properties of delay fields
Lütkenhöner Auditory signal detection appears to depend on temporal integration of subthreshold activity in auditory cortex
HK1241675A1 (en) Neurocerebral assessment using stimulated eeg response
Bai Immediate effects of intermittent theta burst stimulation on the primary motor cortex in patients with stroke: A concurrent TMS-EEG study
Grill Theory and Physiology of Electrical Stimulation of the Central Nervous System

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16746239

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 15547502

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2016746239

Country of ref document: EP